Ligand validation:5YA1

HEZ: HEXANE-1,6-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5YA1_HEZ_A_702	24%	71%	0.321	0.953	0.36	0.73	-	-	0	0	100%	1
5YA1_HEZ_B_602	16%	71%	0.268	0.841	0.36	0.74	-	-	0	0	100%	1
5YA1_HEZ_B_603	2%	71%	0.574	0.886	0.35	0.76	-	-	0	0	100%	1
5YA1_HEZ_A_703	2%	72%	0.633	0.94	0.34	0.74	-	-	0	0	100%	1
5YA2_HEZ_A_602	21%	72%	0.313	0.923	0.38	0.7	-	-	0	0	100%	1
5YA0_HEZ_B_601	3%	73%	0.604	0.934	0.37	0.68	-	-	1	0	100%	1
3WL4_HEZ_B_310	100%	52%	0.038	0.991	1	0.85	-	-	0	0	100%	1
4HLR_HEZ_A_101	94%	63%	0.066	0.964	0.59	0.83	-	-	0	0	100%	1
5XZT_HEZ_E_203	92%	87%	0.071	0.961	0.33	0.36	-	-	0	0	100%	1
4XLZ_HEZ_E_309	91%	73%	0.074	0.96	0.61	0.44	-	-	2	0	100%	1
9HMX_HEZ_A_301	91%	80%	0.086	0.972	0.21	0.62	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.